Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

41.33
Delayed Data
As of 4:02pm ET
 +1.19 / +2.96%
Today’s Change
36.71
Today|||52-Week Range
44.85
+3.89%
Year-to-Date
New Stock Research Reports for June 28, 2016
1:38pm / Zacks.com - Paid Partner Content
How Does Brexit Impact Healthcare Stocks?
Jun 27 / Zacks.com - Paid Partner Content
Shire and Glaxo Offer Prescription to London's Woes
9:29am / TheStreet.com - Paid Partner Content
GlaxoSmithKline (GSK) Flagged As Today's Pre-Market Laggard
Jun 27 / TheStreet.com - Paid Partner Content
Better Buy: NantKwest, Inc. vs. Ionis Pharmaceuticals
9:22am / MotleyFool.com - Paid Partner Content
Post-Brexit Analysis: Should Investors Buy or Sell Biopharma?
Jun 24 / MotleyFool.com - Paid Partner Content
Regulus Therapeutics Inc. Clinical Hold: Should Investors Be Yellow-Bellied?
Jun 27 / MotleyFool.com - Paid Partner Content
Jeff Auxier Sells Precision Castparts, AT&T, Microsoft
Jun 23 / GuruFocus News - Paid Partner Content
Mylan Launches Generic Version of Glaxo's Avodart in U.S.
Jun 27 / Zacks.com - Paid Partner Content
GlaxoSmithKline Has No Cure for Sideways Action
Jun 23 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close40.14
Today’s open40.89
Day’s range40.78 - 41.42
Volume4,148,506
Average volume (3 months)3,460,931
Market cap$97.8B
Dividend yield5.65%
Data as of 4:02pm ET, 06/28/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+15.48%
Earnings growth (next 5 years)+8.20%
Revenue growth (last year)-3.66%
P/E ratio164.5
Price/Sales2.70
Price/Book12.89

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+1.32+2.59%
ABBVAbbVie+1.31+2.23%
SNYSanofi+1.42+3.63%
AGNAllergan+10.24+4.71%
Data as of 4:02pm ET, 06/28/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.59
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts

Partner Offers

Search for Jobs